March is Brain Tumour Awareness Month🎗️🧠 Yesterday, our team stood with Brain Cancer Justice at Parliament Square, to commemorate their petition reaching 100,000 signatures and being delivered to parliament for debate consideration.

#BrainCancerAwarenessMonth #BrainCancerResearch #GBM

Case Western Reserve University faculty member receives Sontag Foundation Distinguished Scientist Award to advance glioblastoma research | CWRU Newsroom | Case Western Reserve University Case Western Reserve University physician-scientist Tyler Miller, MD, PhD (GRS ’16, pathology; MED ’18), has been recognized for his brain cancer...

We’re proud to share that Tyler Miller has received a Sontag Foundation Distinguished Scientist Award supporting his work in glioblastoma research.

The $750,000 award will help drive new strategies to tackle immunosuppression in brain tumors.

Details: bit.ly/4aZwkg6
#Glia #BrainCancerResearch

Breakthroughs like this remind us how far science can reach when we rethink old problems. Who else wants more innovation like this? #BrainCancerResearch #TCSC

Laser Therapy Breakthrough May Extend Survival in Aggressive Brain Cancer Keck Medicine of USC researchers have reported striking early results from a clinical trial that could reshape treatment for one of the deadliest brain cancers.

Researchers at Keck Medicine of USC report a novel laser and immunotherapy combo may meaningfully extend survival in aggressive brain cancer. Hope in a field that needs it most. #BrainCancerResearch #ClinicalInnovation #TCSC
www.coloradoboulevard.net/laser-therap...

Congratulations to Dr. Daniel Schramek at Sinai Health's Lunenfeld-Tanenbaum Research Institute and collaborators on receiving a funding boost to identify genetic drivers of brain cancers from @themarkfdn.bsky.social 👏

Read more here: bit.ly/4rXinG2

#SinaiHealth #BrainCancerResearch #LTRI

At CoSyne, our mission is driven by incredible women scientists. 👩‍🔬💻 On this International Day of Women and Girls in Science, we’re proud to celebrate the innovators on our team.

#WomenInScience #IDWGS2026 #Biotech #BrainCancerResearch #STEM #WomenInSTEM

Today is #WorldCancerDay. In our lifetimes, 1 in 2 of us will face a cancer diagnosis. While 10-year survival rates have reached 50%, progress remains uneven for less survivable cancers like glioblastoma.

#UnitedByUnique #BrainCancer #GBM #DrugDiscovery #BrainCancerResearch

As we approach the end of the year, the team at CANON wishes everyone a happy holidays! ❄️✨ We hope you stay warm, healthy, and safe.

#CANON #AYA #CNS #BrainCancerResearch #Hope

MIT chemists synthesize a fungal compound that holds promise for treating brain cancer

Great news from MIT! 🧪 Their chemists have synthesized a fungal compound showing incredible promise for treating brain cancer, offering a new beacon of hope for future therapies. #ScienceNews #BrainCancerResearch #MedicalBreakthrough 🍄🧠

Mom Was Told Her Tingly Arm Was Anxiety — Then She Collapsed and Received a Devastating Diagnosis Kelsey Stoksted was given a bleak prognosis, but says she's "grateful to be here"

#Medsky #cancersucks #oc #braincancer #cancer #braintumor #fuckcancer #cancersucks #cancerawareness #chemotherapy #cancersurvivor #braincancersucks #braincancersurvivor #braincancerresearch #braintumorawareness #dipg #cancerfighter #braincancerwarrior #dipgawareness #awareness #health #brainhealth

Great to have everyone together for our company offsite yesterday! It’s always great to connect as a full team, celebrate our wins, and align on the next phase of our journey 🙌🧠🚀

#CoSyneTherapeutics #Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch

MYTH vs FACT: Think you know the truth about brain cancer? Let’s break down some common misconceptions! 🧠

Have you heard this myth before? 💭⁉️

#Glioblastoma #GBM #BrainCancer #BrainCancerResearch #BioTech

A huge congratulations to our bioinformatician Grant who conquered the great Steall Marathon in the Scottish Highlands on the weekend! He finished with an impressive time of 7:03 and placed 85 of 231 finishers. 🏃 🏔️ 🎖️

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #Fundraising

🔔 Don't miss a thing! Our journey to fight rare neurological disease is happening on all our social media channels, and we'd love for you to join us.
➕ Follow us on all our pages to get the full story and support our mission.
#Glioblastoma #DrugDiscovery #BrainCancerResearch

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #BioTech #KnowledgeGraphs

Research reveals new therapeutic target to treat brain cancer A paper published in Cell Reports reveals new therapeutic target for glioblastoma in research funded by The Brain Tumour Charity

Exciting research uncovers a new target for glioblastoma treatment! Could this be the breakthrough we've been waiting for? #BrainCancerResearch

www.thebraintumourcharity.org/news/research-news/resea...

We’ve got an incredible interdisciplinary team here at CoSyne; Jo is our experimental biology lead based in our wet lab in Cambridge, and Gui is an engineer who integrates the data generated by our wet lab and computational teams 🔬🥼🖥️🧬

#GBM #Bioinformatics #DrugDiscovery #BrainCancerResearch

CoSyne is dedicated to changing the narrative around brain cancer. Our multidisciplinary team is focused on identifying vulnerabilities in this complex disease, pushing the boundaries of research to develop effective treatments.

#GBM #BrainCancerResearch #DrugDiscovery #BioTech

We’ve got an incredible interdisciplinary team here at CoSyne; Grant and Gregor analyse our genomic data generated in the wet lab, and identify potential drug targets based on this data and other available literature 🖥️🧬🎯

#Glioblastoma #Bioinformatics #DrugDiscovery #BrainCancerResearch

Behind the scenes: our team of bioinformaticians is diving deep into biological data, using cutting-edge analysis to uncover potential new drugs for GBM. Data-driven discovery at its finest! 🔬

#CoSyneTherapeutics #GBM #Bioinformatics #DrugDiscovery #BrainCancerResearch

A new clinical trial is recruiting patients with glioblastoma — the most aggressive brain tumor in adults. KSAT’s The Conversation talks to Dr. Andrew Brenner about the study and how patients can get involved. #Glioblastoma #ClinicalTrial #BrainCancerResearch
youtu.be/5Vm95A-zVcE?...

CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma (GBM) patients.

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

Literature Review | Major Nature Discovery: GABAergic Neurons Drive Diffuse Midline Glioma Growth via Synaptic Signaling Nature study reveals GABAergic synapses between neurons and H3K27M+ DMG cells promote tumor growth, offering new insights for brain cancer therapy.

🧠✨This study is the first to clearly demonstrate the presence of growth-promoting synaptic communication between GABAergic neurons and H3K27M+ DMG cells

📍Learn more:
www.ebraincase.com/support/lite...

www.nature.com/articles/s41...

#Neuroscience #BrainCancerResearch #Glioma #BrainCaseBiotech

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

For diseases like GBM, where treatment options remain limited, every insight counts. [14/14]

#Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

CoSyne Therapeutics is committed to advancing new treatment options for glioblastoma patients.

Read more about our work on our website: www.cosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

GBM patients have faced decades without a new approved therapy.

At CoSyne, we’re working on something that could change that. Stay tuned.

www.gliosyne.com

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech

The last FDA-approved therapy for glioblastoma (GBM) was in 2009.

15 years with no new treatments — patients deserve better.

Follow us for updates on what we're doing to bring new treatments to patients.

#CoSyneTherapeutics #Glioblastoma #BrainCancerResearch #DrugDiscovery #BioTech